Needle, subcutaneous injection/infusion port
Access comprehensive regulatory information for Needle, subcutaneous injection/infusion port in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Medtronic Australasia Pty Ltd, manufactured by Unomedical A/S in Denmark. The device registration started on August 19, 2014.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
The i-port Advance™ injection port is indicated for patients who administer, or to whom is administered, multiple daily subcutaneous injections of physician prescribed medications, including insulin.